lncAP003419.16 is highly expressed in TGFβ1‐treated alveolar epithelial cells and IPF patients,27 in which lncAP003419.16 facilitates pulmonary fibrosis via the mammalian target of rapamycin (mTOR) signaling pathway dependent on its adjacent gene ribosomal protein S6 kinase B‐2 (RPS6KB2). The gene discussed is RPS6KB2; the disease is idiopathic pulmonary fibrosis.